跳至主要内容
临床试验/EUCTR2010-023878-40-AT
EUCTR2010-023878-40-AT进行中(未招募)1 期

Influence of intra-arterial cerebral Papaverine Hydrochloride on cerebral glucose, lactate, pyruvate, glycerol, and glutamate concentrations, cerebral oxygenation, angiographic vasospasm, delayed stroke rates, and neurologic outcome in patients suffering life-threatening post-subarachnoid hemorrhage cerebral vasospasm irresponsive to hyperdynamic treatment.

Medical University Vienna0 个研究点目标入组 20 人开始时间: 2011年12月5日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patient age > 18 yrs.
  • Aneurysmal SAH
  • Saccular and fusiform cerebral aneurysm
  • Aneurysm treated by surgery or embolisation
  • Severe post SAH VSP irresponsive to hyperdynamic therapy
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • Intracranial hypertension obviating patient transport
  • Delayed VSP related strokes on cerebral CT scans

研究者

发起方
Medical University Vienna

相似试验